MYOVENTRICULOPLASTY AND NEOVENTRICLE MYOGRAFT CARDIAC AUGMENTATION TO ESTABLISH PULMONARY BLOOD-FLOW - PRELIMINARY-OBSERVATIONS AND FEASIBILITY STUDIES JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Macoviak, J. A., Stinson, E. B., Starkey, T. D., Hansen, D. E., CAHILL, P. D., Miller, D. C., Shumway, N. E. 1987; 93 (2): 212-220

Abstract

In 10 dogs, a latissimus dorsi muscle (myograft) was neuroelectrically stimulated at 120 cycles/min for as long as 80 days. The higher thresholds and multiple lead penetrations required of direct muscle stimulation for muscle conditioning were avoided. Vascular delay and protective wrapping of the myograft in four dogs resulted in rapid seroma and fibrous sheath formation, which precluded further study. Of the six other myografts that were stimulated, two were used as functional right ventricular myoventriculoplasties and four were employed as neoventricle myografts with inflow and outflow valved conduits that were used to provide total pulmonary blood flow. Myoventriculoplasty produced functional enlargement of the right ventricle with synchronously contractile muscle. Neoventricles provided hemodynamically stable total pulmonary blood flow for as long as 20 hours, until internal chamber thrombus formed. Transpulmonary blood pressure generation by the neoventricle was found to be programmable up to physiologic systemic pressures by modulation of chamber preload and burst stimulation frequency at 50 msec intervals, delivered 120 times per minute. Synchronization capabilities for implantable burst pulse generators would further improve the efficacy of these myograft techniques designed to augment or supplant ventricular function, particularly to provide transpulmonary blood flow at programmable pressures.

View details for Web of Science ID A1987F936800006

View details for PubMedID 3807397